Aptar makes digital health play, agreeing deal to buy Voluntis
pharmaphorum
JULY 27, 2021
Drug delivery specialist Aptar Group has agreed a deal to take a near two-thirds share in Voluntis, a French developer of digital therapeutics (DTx), with a view to taking full control of the company later this year. per share in the initial deal, which will give it a 64.6% stake in the company. stake in the company.
109 
Let's personalize your content